1. |
FERLAY J, SHIN H R, BRAY F, et al. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008[J]. Int J Cancer, 2010, 127(12): 2893-2917.
|
2. |
GALASKO C S B. Skeletal metastases[J]. Clin Orthop Relat Res, 1986, (210):18-30.
|
3. |
JACOBSON A F, CRONIN E B, STOMPER P C, et al. Bone scans with one or two new abnormalities in cancer patients with no known metastases: frequency and serial scintigraphic behavior of benign and malignant lesions[J]. Radiology, 1990, 175(1): 229-232.
|
4. |
JACOBSON A F, STOMPER P C, CRONIN E B, et al. Bone scans with one or two new abnormalities in cancer patients with no known metastases: reliability of interpretation of initial correlative radiographs[J]. Radiology, 1990, 174(2): 503-507.
|
5. |
NAKANISHI K, KOBAYASHI M, TAKAHASHI S, et al. Whole body MRI for detecting metastatic bone tumor: comparison with bone scintigrams[J]. Magn Reson Med Sci, 2005, 4(1): 11-17.
|
6. |
ENGELHARD K, HOLLENBACH H P, WOHLFART K, et al. Comparison of whole-body MRI with automatic moving table technique and bone scintigraphy for screening for bone metastases in patients with breast cancer[J]. Eur Radiol, 2004, 14(1): 99-105.
|
7. |
FRAT A, AGLDERE M, GENOGLU A, et al. Value of whole-body turbo short tau inversion recovery magnetic resonance imaging with panoramic table for detecting bone metastases: comparison with 99MTc-methylene diphosphonate scintigraphy[J]. J Comput Assist Tomogr, 2006, 30(1): 151-156.
|
8. |
GHANEM N, KELLY T, ALTEHOEFER C, et al. Whole-body MRI in comparison to skeletal scintigraphy for detection of skeletal metastases in patients with solid tumors[J]. Radiologe, 2004, 44(9): 864-873.
|
9. |
VANDE BERG B V, LECOUVET F E, MICHAUX L, et al. Magnetic resonance imaging of the bone marrow in hematological malignancies[J]. Eur Radiol, 1998, 8(8): 1335-1344.
|
10. |
SCHIRRMEISTER H, GUHLMANN A, ELSNER K, et al. Sensitivity in detecting osseous lesions depends on anatomic localization: planar bone scintigraphy versus 18F PET[J]. J Nucl Med, 1999, 40(10):1623-1629.
|
11. |
TOMBAL B, REZAZADEH A, THERASSE P, et al. Magnetic resonance imaging of the axial skeleton enables objective measurement of tumor response on prostate cancer bone metastases[J]. Prostate, 2005, 65(2): 178-187.
|
12. |
KOH D M, TAKAHARA T, IMAI Y, et al. Practical aspects of assessing tumors using clinical diffusion-weighted imaging in the body[J]. Magn Reson Med Sci, 2007, 6(4): 211-224.
|
13. |
LOW R N. Abdominal MRI advances in the detection of liver tumours and characterisation[J]. Lancet Oncol, 2007, 8(6): 525-535.
|
14. |
BERLIN J A. Does blinding of readers affect the results of meta-analyses?[J]. Lancet, 1997, 350: 185-186.
|
15. |
WHITING P, RUTJES A W, REITSMA J B, et al. The development of QUADAS: a tool for the quality assessment of studies of diagnostic accuracy included in systematic reviews[J]. BMC Med Res Methodol, 2003, 3(1): 25.
|
16. |
WHITING P, WESWOOD M E, RUTJES A W, et al. Evaluation of QUADAS, a tool for the quality assessment of diagnostic accuracy studies[J]. BMC Med Res Methodol, 2006, 6(1): 9.
|
17. |
谢纪宝, 陈江涛, 宋兴华. 18F-FDG PET/CT与99Tcm-MDP骨显像诊断肿瘤骨转移价值的Meta分析[J]. 中国循证医学杂志, 2011, 11(6): 655-660.
|
18. |
LECOUVET F E, EL MOUEDDEN J, COLLETTE L, et al. Can whole-body magnetic resonance imaging with diffusion-weighted imaging replace Tc 99m bone scanning and computed tomography for single-step detection of metastases in patients with high-risk prostate cancer?[J]. Eur Urol, 2012, 62(1): 68-75.
|
19. |
LECOUVET F E, GEUKENS D, STAINIER A, et al. Magnetic resonance imaging of the axial skeleton for detecting bone metastases in patients with high-risk prostate cancer: diagnostic and cost-effectiveness and comparison with current detection strategies[J]. J Clin Oncol , 2007, 25(22): 3281-3287.
|
20. |
MOSAVI F, JOHANSSON S, SANDBERG D T, et al. Whole-body diffusion-weighted MRI compared with (18)F-NaF PET/CT for detection of bone metastases in patients with high-risk prostate carcinoma[J]. AJR Am J Roentgenol, 2012, 199(5): 1114-1120.
|
21. |
VENKITARAMAN R, COOK G J, DEARNALEY D P, et al. Does magnetic resonance imaging of the spine have a role in the staging of prostate cancer?[J]. Clin Oncol (R Coll Radiol), 2009, 21(1): 39-42.
|
22. |
VENKITARAMAN R, COOK G J, DEARNALEY D P, et al. Whole-body magnetic resonance imaging in the detection of skeletal metastases in patients with prostate cancer[J]. J Med Imaging Radiat Oncol, 2009, 53(3): 241-247.
|
23. |
张天嵩, 钟文昭. Meta-DiSc软件在诊断试验Meta分析中的应用[J]. 循证医学, 2008, 8(2): 97-100.
|
24. |
GOSFIELD E, ALAVI A, KNEELAND B. Comparison of radionuclide bone scans and magnetic resonance imaging in detecting spinal metastases[J]. J Nucl Med, 1993, 34(12): 2191-2198.
|
25. |
STEINBORN M M, HEUCK A F, TILING R, et al. Whole-body bone marrow MRI in patients with metastatic disease to the skeletal system[J]. J Comput Assist Tomogr, 1999, 23(1): 123-129.
|
26. |
DWAMENA B A, SONNAD S S, ANGOBALDO J O, et al. Metastases from non-small cell lung cancer: mediastinal staging in the 1990s-meta-analytic comparison of PET and CT[J]. Radiol, 1999, 213(2): 530-536.
|
27. |
TRYCIECKY E W, GOTTSCHALK A, LUDEMA K. Oncologic imaging: interactions of nuclear medicine with CT and MRI using the bone scan as a model[J].Semin Nucl Med, 1997,27(2):142-151.
|
28. |
COOK G J, FOGELMAN I. The role of positron emission tomography in the management of bone metastases[J]. Cancer, 2000, 88(12 Suppl): S2927-S2933.
|
29. |
LOEFFLER R K, DISIMONE R N, HOWLAND W J. Limitations of bone scanning in clinical oncology[J]. JAMA, 1975, 234(12): 1228-1232.
|
30. |
李芸芝,马彬,杨克虎,等. MRI和骨扫描对乳腺癌骨转移诊断价值的Meta分析[J]. 中国循证医学杂志, 2010, 10(10): 1159-11563.
|